fda removes tirzepatide FDA's decision creates uncertainty for patients—and leads to a lawsuit Lilly's weight-loss drug removed from

If the IRA-negotiated price is indeed separately calculated (and probably higher than the $245 number), then perhaps the $245 figure will apply in Medicare through a Center for Medicare and Medicaid Innovation pilot program

Ozempic and Mounjaro hover around $1k/month, and Wegovy can be $1.3k or more

Is AlloClae safe for volume restoration

That likely means that millions of used injection devices are being discarded each week, prompting questions about proper disposal and potential environmental impacts long after the injection devices arrive at a landfill

For others, the digestive tract reacts strongly

For researchers using tirzepatide sourced from vendors with known weight accuracy issues, an additional safety consideration arises